Department of Uro-Oncology, University College London Hospital , Oxford , United Kingdom.
Division of Surgery and Interventional Sciences, University College London , Oxford , United Kingdom.
J Urol. 2019 Jun;201(6):1134-1143. doi: 10.1097/JU.0000000000000135.
We describe the pathological characteristics of recurrence following high intensity focused ultrasound partial ablation in men treated with salvage robot-assisted radical prostatectomy. We assessed the sensitivity of magnetic resonance imaging before salvage robot-assisted radical prostatectomy in these men.
A total of 35 men underwent salvage robot-assisted radical prostatectomy after high intensity focused ultrasound partial ablation from 2012 to 2018. We compared clinicopathological characteristics before ultrasound and before salvage prostatectomy after ultrasound to histopathology on salvage prostatectomy. We assessed infield recurrence, out of field disease, positive surgical margins and magnetic resonance imaging sensitivity before salvage robot-assisted radical prostatectomy.
Before high intensity focused ultrasound 55.9% of men had multifocal disease and 47.1% had Gleason 3 + 3 disease outside the treatment field. Median time to salvage prostatectomy was 16 months (IQR 11-26). Indications for salvage prostatectomy were infield recurrence in 55.8% of cases, out of field recurrence in 20.6%, and infield and out of field recurrence in 23.5%. On salvage prostatectomy histopathology revealed significant cancer, defined as ISUP (International Society of Urological Pathology) 2 or greater, infield in 97.1% of cases, out of field in 81.3%, and infield and out of field in 79.4%. Of the cases 82.4% were adversely reclassified at salvage prostatectomy compared to 67.6% before ultrasound. The positive surgical margin rate was 40.0%. Of the positive margins 84.6% were in the region of previous ultrasound despite wide excision, including pT2 in 28.6%, pT3 in 47.6% and size 3 mm or greater, pT3 or multifocal (ie significant) in 31.4%. After ultrasound the sensitivity of magnetic resonance imaging for infield and out of field recurrence was 81.8% and 60.7%, respectively.
Salvage robot-assisted radical prostatectomy may confer a higher risk of positive surgical margins, upgrading and up-staging than primary robot-assisted radical prostatectomy. High intensity focused ultrasound carries a risk of recurrence inside and outside the ablation zone. This information may inform salvage surgical planning and patient counseling regarding the choice of initial therapy and salvage treatment after high intensity focused ultrasound.
我们描述了高强度聚焦超声部分消融后接受挽救性机器人辅助根治性前列腺切除术治疗的男性患者复发的病理特征。我们评估了这些男性患者在挽救性机器人辅助根治性前列腺切除术前磁共振成像的敏感性。
2012 年至 2018 年间,共有 35 名男性患者在高强度聚焦超声部分消融后接受挽救性机器人辅助根治性前列腺切除术。我们比较了超声前和超声后前列腺切除术的临床病理特征与前列腺切除术的组织病理学。我们评估了挽救性机器人辅助根治性前列腺切除术前的场内复发、场外疾病、阳性手术切缘和磁共振成像的敏感性。
高强度聚焦超声前,55.9%的男性患者有多灶性疾病,47.1%的患者在治疗场外有 Gleason3+3 疾病。挽救性前列腺切除术的中位时间为 16 个月(IQR 11-26)。挽救性前列腺切除术的适应证为场内复发 55.8%,场外复发 20.6%,场内和场外复发 23.5%。挽救性前列腺切除术后组织病理学显示,97.1%的病例有明显的癌症,定义为国际泌尿病理学会(ISUP)2 级或更高,81.3%的病例有场外复发,79.4%的病例有场内和场外复发。与超声前相比,82.4%的病例在挽救性前列腺切除术后被重新分类为不利。阳性手术切缘率为 40.0%。尽管广泛切除,阳性切缘中 84.6%位于先前超声区域,包括 28.6%的 pT2、47.6%的 pT3 和 3mm 或更大、31.4%的 pT3 或多灶性(即显著)。超声后,磁共振成像对场内和场外复发的敏感性分别为 81.8%和 60.7%。
与原发性机器人辅助根治性前列腺切除术相比,挽救性机器人辅助根治性前列腺切除术可能导致更高的阳性手术切缘率、升级和分期。高强度聚焦超声有在消融区内外复发的风险。这些信息可能为挽救性手术计划提供信息,并为患者提供关于初始治疗和高强度聚焦超声后挽救性治疗选择的咨询。